Key Metrics of Merck & Co.
Revenue$60.1B▲ 1.4% YoYFY 2023
Operating income—
Net profit$365M▼ 97.5% YoY
Shareholders' equity$37.6B
Market cap$366BMRK · $148.30
Competitors10identified
About Merck & Co.
Sectors
Company details
- Website
- merck.com
- Listed
- NYSE: MRK
Operational Areas of Merck & Co.
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameMerck & Company Inc.
TickerMRK
ExchangeNYSE
CountryUnited States
SEC CIK0000310158
Listed since—
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttps://www.merck.com
US market & SEC filings
MRK · NYSE · SEC CIK 0000310158
Last price · 22 Oct 2026
$148.30
+3.25%
Market cap$366B
P/E1,059.3On FY 2023 diluted EPS
Volume9,923,572
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited States
MRK share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeRahway
GSTIN—
Email—
Websitehttps://www.merck.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Merck & Co.
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.